Investor and operating executive with experience in growth-stage technology, SaaS go-to-market and corporate development across venture and private equity-backed businesses. Kristy DeJarnette brings leadership in scaling sales, partnerships and M&A execution, having led commercial strategy and investor relations roles and advised multiple startups on capital raises. Market-relevant strengths include revenue operations, board-level governance and sector-focused deal sourcing.
Investor and operating executive with experience in growth-stage technology, SaaS go-to-market and corporate development across venture and private equity-backed businesses. Kristy DeJarnette brings leadership in scaling sales, partnerships and M&A execution, having led commercial strategy and investor relations roles and advised multiple startups on capital raises. Market-relevant strengths include revenue operations, board-level governance and sector-focused deal sourcing.
Targets growth-stage technology and SaaS businesses where commercial scaling can unlock value. Prefers revenue-first KPIs, repeatable GTM motions and capital-efficient expansion; invests with a 3–7 year horizon balancing growth capture and path-to-profitability. Underwrites deals through customer traction, unit economics and founder/operator alignment, brings active capital via go-to-market playbooks, board governance and M&A optionality. Risk-managed through staged commitments, milestone-based funding and emphasis on partnership-led distribution.
Targets growth-stage technology and SaaS businesses where commercial scaling can unlock value. Prefers revenue-first KPIs, repeatable GTM motions and capital-efficient expansion; invests with a 3–7 year horizon balancing growth capture and path-to-profitability. Underwrites deals through customer traction, unit economics and founder/operator alignment, brings active capital via go-to-market playbooks, board governance and M&A optionality. Risk-managed through staged commitments, milestone-based funding and emphasis on partnership-led distribution.
| Trades 1411 | Longs Won 1089/1411 77% | Profit Factor 16.62 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.1M |
| Average Win $177,237.71 | Best Trade (Mar 31) $27.14M | Sharpe Ratio -56.31 |
| Average Loss -$36,076.88 | Worst Trade (Aug 19) -$5.08M | Z-Score 21.89 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 4w | Expectancy $128,557.84 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 16,949 | 15,254 | 13,559 | 11,864 | 10,169 | 8,475 | 6,780 | 5,085 | 3,390 | 1,695 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 9170 91703D100 | 13,052 | $36,285 | $36,285 | - | - | - | 0.0 |
AAPL Apple Inc. | 50,932 | $8.81M | $15.53M | - | $6.72M | 76.25% | -1.087% |
ABBV AbbVie Inc. | 3,178 | $486,374.89 | $788,048.66 | - | $301,673.77 | 62.02% | 0.0 |
ABT Abbott Laboratories | 3,679 | $358,811.67 | $403,659.88 | - | $44,848.21 | 12.5% | +1.013% |
AEM Agnico Eagle Mines Limited | 1,311 | $220,982.01 | $236,609.28 | - | $15,627.27 | 7.07% | 0.0 |
ALNY Alnylam Pharmaceuticals Inc | 750 | $225,773 | $165,900 | - | -$59,873 | -26.52% | +1.945% |
AMAT Applied Materials, Inc. | 537 | $388,459 | $280,378.44 | - | -$108,080.56 | -27.82% | 0.0 |
AMD Advanced Micro Devices, Inc. | 6,426 | $1.41M | $3.02M | - | $1.61M | 113.95% | 0.0 |
AMGN Amgen Inc. | 1,352 | $364,519.81 | $564,054.4 | - | $199,534.59 | 54.74% | 0.0 |
AMZN Amazon.com Inc | 26,181 | $4.34M | $7.13M | - | $2.79M | 64.4% | -2.093% |
ANET Arista Networks, Inc. | 5,204 | $609,587.64 | $1.03M | - | $420,023.76 | 68.9% | +3.305% |
APH Amphenol Corporation | 5,396 | $397,079.93 | $452,454.6 | - | $55,374.67 | 13.95% | 0.0 |
AROC Archrock Inc. | 12,150 | $304,806.26 | $400,828.5 | - | $96,022.24 | 31.5% | -0.423% |
ASML ASML Holding N.V. New York Registry Shares | 255 | $378,933.67 | $458,841.9 | - | $79,908.23 | 21.09% | +3.802% |
AVGO Broadcom Inc. | 6,073 | $891,119.02 | $2.57M | - | $1.67M | 187.87% | 0.0 |
AXP American Express Company | 7,488 | $1.12M | $2.54M | - | $1.42M | 126.92% | 0.0 |
BABA Alibaba Group Holding Limited SP ADR | 4,018 | $360,053.24 | $513,701.3 | - | $153,648.06 | 42.67% | -3.378% |
BAC Bank of America Corporation | 9,290 | $281,332 | $593,259.4 | - | $311,927.4 | 110.88% | 0.0 |
BN Brookfield Corporation | 7,451 | $199,291.9 | $329,930.28 | - | $130,638.38 | 65.55% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 37,960 | $13.47M | $20.1M | - | $6.63M | 49.24% | 0.0 |